Michael Beauvais

Ropes & Gray - UNITED STATES


Michael Beauvais's competencies

Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Corporate M&AUNITED STATES221727033583
Life Science & Health CareUNITED STATES87105027705
Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Showing 1 to 2 of 2 entries

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

0255075100Below expectationMeet expectationExceed expectation0

Technical skills

0255075100Below expectationMeet expectationExceed expectation0

Efficiency

0255075100Below expectationMeet expectationExceed expectation0


Effectiveness

0255075100Below expectationMeet expectationExceed expectation0



Perceived Added Value

0255075100

Ranking 2022: Michael Beauvais - Ropes & Gray

Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Corporate M&A27033583
Life Science & Health Care105027705
Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Showing 1 to 2 of 2 entries

Ranking 2021: Michael Beauvais - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Life Science & Health Care185042502
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Michael Beauvais - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Corporate M&A16517882
Equity Capital Markets55251
Life Science & Health Care77528333
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Michael Beauvais's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
Eli Lilly and CompanyCardinal Health, Inc.Blackstone Life SciencesBain Capital Life SciencesAvenCell Therapeutics05K10KRevenue (ML. Euro)

Team

The chart shows a balanced list of counselor working with Michael Beauvais - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Rajarshi BanerjeeRenata FerrariPamela GlazierLisa KaltenbrunnerDavid KayeSteve KayeRuchit PatelRaymond GrantOliver NipMilap PatelMichael McFallsMichael LampertMichael ConnollyMegan BiskMegan Baca Kellie CombsJoshua LichtensteinJordan AltmanJonathan HemptonJane WillisHarvey CottonGeorgina Jones SuzukiFran FairclothEric Behl-RemijanEmily OldshueDouglas BrayleyDeidre JohnsonDaniel CoyneConnie ShenChrista SanchezBryan LowranceBrendan HanifinBoxin WangArthur MokAlyce Chen02K4KAgg. deal value (ML. Euro)

Co-Counsel

The Chart shows a balanced list of Michael Beauvais's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Goodwin Procter01.75K3.5KAgg. deal value (ML. Euro)

Counterparts

The Chart shows a balanced list of Michael Beauvais's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Kirkland & EllisPaul Hastings LLPWilson Sonsini Goodrich & Rosati02K4KAgg. deal value (ML. Euro)

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


0%20%40%60%80%100%Communication SkillsTechnical skillsEfficiencyEffectivenessPerceived Added Value

Recent experiences

Novartis’ $3.1 Billion Acquisition of Anthos Therapeutics2/19/2025
Eli Lilly's $2.5 Billion Acquisition of Scorpion Therapeutics and its PI3Kα Cancer Program1/15/2025
AvenCell Therapeutics' $112 Million Series B Funding Round10/28/2024
Cardinal Health's $1.1 Billion Acquisition of Oncology Network9/25/2024
Serán Bioscience's $200 Million Investment Round9/24/2024